nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP1A1—Clobetasol propionate—psoriasis	0.054	0.0701	CbGbCtD
Phenobarbital—CYP4A11—Dexamethasone—psoriasis	0.0447	0.0579	CbGbCtD
Phenobarbital—CYP2A6—Methoxsalen—psoriasis	0.0332	0.0431	CbGbCtD
Phenobarbital—ABCC3—Cyclosporine—psoriasis	0.0326	0.0423	CbGbCtD
Phenobarbital—CYP1A1—Methoxsalen—psoriasis	0.0284	0.0368	CbGbCtD
Phenobarbital—ABCB11—Cyclosporine—psoriasis	0.0282	0.0365	CbGbCtD
Phenobarbital—CYP2C8—Tazarotene—psoriasis	0.0254	0.033	CbGbCtD
Phenobarbital—CYP3A5—Beclomethasone—psoriasis	0.0246	0.0319	CbGbCtD
Phenobarbital—CYP1A2—Clobetasol propionate—psoriasis	0.0241	0.0313	CbGbCtD
Phenobarbital—ABCC1—Cyclosporine—psoriasis	0.02	0.0259	CbGbCtD
Phenobarbital—ABCC2—Mycophenolate mofetil—psoriasis	0.0195	0.0253	CbGbCtD
Phenobarbital—CYP1A1—Cholecalciferol—psoriasis	0.0188	0.0244	CbGbCtD
Phenobarbital—ABCB11—Dexamethasone—psoriasis	0.0185	0.024	CbGbCtD
Phenobarbital—CYP1B1—Dexamethasone—psoriasis	0.0185	0.024	CbGbCtD
Phenobarbital—ABCC3—Methotrexate—psoriasis	0.0172	0.0224	CbGbCtD
Phenobarbital—CYP2A6—Prednisolone—psoriasis	0.0162	0.0209	CbGbCtD
Phenobarbital—ABCC2—Cyclosporine—psoriasis	0.0148	0.0192	CbGbCtD
Phenobarbital—CYP2B6—Cholecalciferol—psoriasis	0.0143	0.0186	CbGbCtD
Phenobarbital—CYP1A2—Methoxsalen—psoriasis	0.0127	0.0164	CbGbCtD
Phenobarbital—CYP2C8—Cholecalciferol—psoriasis	0.0109	0.0141	CbGbCtD
Phenobarbital—ABCC1—Methotrexate—psoriasis	0.0106	0.0137	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0105	0.0136	CbGbCtD
Phenobarbital—CYP3A7—Hydrocortisone—psoriasis	0.0105	0.0136	CbGbCtD
Phenobarbital—CYP3A7—Cyclosporine—psoriasis	0.00989	0.0128	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00989	0.0128	CbGbCtD
Phenobarbital—CYP3A5—Mycophenolate mofetil—psoriasis	0.00979	0.0127	CbGbCtD
Phenobarbital—ABCC2—Dexamethasone—psoriasis	0.00975	0.0126	CbGbCtD
Phenobarbital—CYP2A6—Dexamethasone—psoriasis	0.00952	0.0124	CbGbCtD
Phenobarbital—CYP2C8—Mycophenolate mofetil—psoriasis	0.00941	0.0122	CbGbCtD
Phenobarbital—CYP2C19—Cholecalciferol—psoriasis	0.0091	0.0118	CbGbCtD
Phenobarbital—CYP3A4—Calcitriol—psoriasis	0.00854	0.0111	CbGbCtD
Phenobarbital—CYP1A1—Dexamethasone—psoriasis	0.00814	0.0106	CbGbCtD
Phenobarbital—CYP3A5—Hydrocortisone—psoriasis	0.00785	0.0102	CbGbCtD
Phenobarbital—ABCC2—Methotrexate—psoriasis	0.00784	0.0102	CbGbCtD
Phenobarbital—CYP2C9—Cholecalciferol—psoriasis	0.00757	0.00982	CbGbCtD
Phenobarbital—CYP2C8—Hydrocortisone—psoriasis	0.00755	0.00979	CbGbCtD
Phenobarbital—CYP3A5—Cyclosporine—psoriasis	0.00742	0.00962	CbGbCtD
Phenobarbital—CYP2C8—Cyclosporine—psoriasis	0.00713	0.00925	CbGbCtD
Phenobarbital—CYP3A4—Methoxsalen—psoriasis	0.00664	0.00862	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00651	0.00844	CbGbCtD
Phenobarbital—CYP3A7—Dexamethasone—psoriasis	0.00651	0.00844	CbGbCtD
Phenobarbital—ABCB1—Mycophenolate mofetil—psoriasis	0.00637	0.00826	CbGbCtD
Phenobarbital—CYP2C19—Prednisone—psoriasis	0.00631	0.00818	CbGbCtD
Phenobarbital—CYP2E1—Dexamethasone—psoriasis	0.00629	0.00815	CbGbCtD
Phenobarbital—CYP2B6—Dexamethasone—psoriasis	0.0062	0.00804	CbGbCtD
Phenobarbital—CYP2C19—Cyclosporine—psoriasis	0.00598	0.00776	CbGbCtD
Phenobarbital—ABCB1—Betamethasone—psoriasis	0.00546	0.00709	CbGbCtD
Phenobarbital—ABCB1—Prednisolone—psoriasis	0.00539	0.00699	CbGbCtD
Phenobarbital—ABCB1—Hydrocortisone—psoriasis	0.00511	0.00663	CbGbCtD
Phenobarbital—ABCB1—Prednisone—psoriasis	0.00509	0.0066	CbGbCtD
Phenobarbital—CYP2C9—Cyclosporine—psoriasis	0.00497	0.00645	CbGbCtD
Phenobarbital—CYP3A5—Dexamethasone—psoriasis	0.00488	0.00633	CbGbCtD
Phenobarbital—ABCB1—Cyclosporine—psoriasis	0.00483	0.00626	CbGbCtD
Phenobarbital—CYP2C8—Dexamethasone—psoriasis	0.0047	0.00609	CbGbCtD
Phenobarbital—CYP3A4—Cholecalciferol—psoriasis	0.0044	0.00571	CbGbCtD
Phenobarbital—CYP2C19—Dexamethasone—psoriasis	0.00394	0.00511	CbGbCtD
Phenobarbital—CYP3A4—Mycophenolate mofetil—psoriasis	0.00382	0.00495	CbGbCtD
Phenobarbital—CYP3A4—Triamcinolone—psoriasis	0.00382	0.00495	CbGbCtD
Phenobarbital—CYP2C9—Dexamethasone—psoriasis	0.00328	0.00425	CbGbCtD
Phenobarbital—CYP3A4—Betamethasone—psoriasis	0.00327	0.00425	CbGbCtD
Phenobarbital—CYP3A4—Prednisolone—psoriasis	0.00323	0.00419	CbGbCtD
Phenobarbital—ABCB1—Dexamethasone—psoriasis	0.00318	0.00412	CbGbCtD
Phenobarbital—CYP3A4—Hydrocortisone—psoriasis	0.00306	0.00397	CbGbCtD
Phenobarbital—CYP3A4—Prednisone—psoriasis	0.00305	0.00396	CbGbCtD
Phenobarbital—CYP3A4—Cyclosporine—psoriasis	0.00289	0.00375	CbGbCtD
Phenobarbital—ABCB1—Methotrexate—psoriasis	0.00255	0.00331	CbGbCtD
Phenobarbital—CYP3A4—Dexamethasone—psoriasis	0.0019	0.00247	CbGbCtD
Phenobarbital—Arthralgia—Mycophenolic acid—psoriasis	0.000216	0.00147	CcSEcCtD
Phenobarbital—Anxiety—Mycophenolic acid—psoriasis	0.000215	0.00146	CcSEcCtD
Phenobarbital—Irritability—Prednisone—psoriasis	0.000215	0.00146	CcSEcCtD
Phenobarbital—Mood swings—Prednisone—psoriasis	0.000213	0.00145	CcSEcCtD
Phenobarbital—Bradycardia—Hydrocortisone—psoriasis	0.000213	0.00145	CcSEcCtD
Phenobarbital—Constipation—Hydroxyurea—psoriasis	0.000211	0.00143	CcSEcCtD
Phenobarbital—Pain—Hydroxyurea—psoriasis	0.000211	0.00143	CcSEcCtD
Phenobarbital—Nausea—Calcitriol—psoriasis	0.00021	0.00143	CcSEcCtD
Phenobarbital—Confusional state—Mycophenolic acid—psoriasis	0.000208	0.00142	CcSEcCtD
Phenobarbital—Hallucination—Hydrocortisone—psoriasis	0.000208	0.00141	CcSEcCtD
Phenobarbital—Dizziness—Acitretin—psoriasis	0.000208	0.00141	CcSEcCtD
Phenobarbital—Dizziness—Fluocinolone Acetonide—psoriasis	0.000207	0.00141	CcSEcCtD
Phenobarbital—Feeling abnormal—Hydroxyurea—psoriasis	0.000203	0.00138	CcSEcCtD
Phenobarbital—Shock—Mycophenolic acid—psoriasis	0.000203	0.00138	CcSEcCtD
Phenobarbital—Tension—Cyclosporine—psoriasis	0.000201	0.00137	CcSEcCtD
Phenobarbital—Bradycardia—Triamcinolone—psoriasis	0.000201	0.00136	CcSEcCtD
Phenobarbital—Vomiting—Acitretin—psoriasis	0.0002	0.00136	CcSEcCtD
Phenobarbital—Vomiting—Fluocinolone Acetonide—psoriasis	0.000199	0.00135	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Methotrexate—psoriasis	0.000199	0.00135	CcSEcCtD
Phenobarbital—Nervousness—Cyclosporine—psoriasis	0.000199	0.00135	CcSEcCtD
Phenobarbital—Rash—Acitretin—psoriasis	0.000198	0.00135	CcSEcCtD
Phenobarbital—Dermatitis—Acitretin—psoriasis	0.000198	0.00135	CcSEcCtD
Phenobarbital—Rash—Fluocinolone Acetonide—psoriasis	0.000198	0.00134	CcSEcCtD
Phenobarbital—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000197	0.00134	CcSEcCtD
Phenobarbital—Headache—Acitretin—psoriasis	0.000197	0.00134	CcSEcCtD
Phenobarbital—Headache—Fluocinolone Acetonide—psoriasis	0.000196	0.00133	CcSEcCtD
Phenobarbital—Tension—Mycophenolate mofetil—psoriasis	0.000196	0.00133	CcSEcCtD
Phenobarbital—Body temperature increased—Hydroxyurea—psoriasis	0.000195	0.00133	CcSEcCtD
Phenobarbital—Nervousness—Mycophenolate mofetil—psoriasis	0.000194	0.00132	CcSEcCtD
Phenobarbital—Hypotension—Mycophenolic acid—psoriasis	0.000193	0.00131	CcSEcCtD
Phenobarbital—Lethargy—Methotrexate—psoriasis	0.000192	0.0013	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000188	0.00128	CcSEcCtD
Phenobarbital—Agitation—Cyclosporine—psoriasis	0.000188	0.00128	CcSEcCtD
Phenobarbital—Angioedema—Cyclosporine—psoriasis	0.000187	0.00127	CcSEcCtD
Phenobarbital—Nausea—Acitretin—psoriasis	0.000187	0.00127	CcSEcCtD
Phenobarbital—Erythema—Prednisolone—psoriasis	0.000186	0.00127	CcSEcCtD
Phenobarbital—Nausea—Fluocinolone Acetonide—psoriasis	0.000186	0.00127	CcSEcCtD
Phenobarbital—Vertigo—Cyclosporine—psoriasis	0.000184	0.00125	CcSEcCtD
Phenobarbital—Somnolence—Mycophenolic acid—psoriasis	0.000184	0.00125	CcSEcCtD
Phenobarbital—Agitation—Mycophenolate mofetil—psoriasis	0.000184	0.00125	CcSEcCtD
Phenobarbital—Angioedema—Mycophenolate mofetil—psoriasis	0.000183	0.00124	CcSEcCtD
Phenobarbital—Erythema—Hydrocortisone—psoriasis	0.000182	0.00124	CcSEcCtD
Phenobarbital—Bradycardia—Dexamethasone—psoriasis	0.000182	0.00124	CcSEcCtD
Phenobarbital—Bradycardia—Betamethasone—psoriasis	0.000182	0.00124	CcSEcCtD
Phenobarbital—Hypersensitivity—Hydroxyurea—psoriasis	0.000182	0.00124	CcSEcCtD
Phenobarbital—Vertigo—Mycophenolate mofetil—psoriasis	0.00018	0.00122	CcSEcCtD
Phenobarbital—Irritability—Methotrexate—psoriasis	0.000179	0.00122	CcSEcCtD
Phenobarbital—Syncope—Mycophenolate mofetil—psoriasis	0.000179	0.00122	CcSEcCtD
Phenobarbital—Mood swings—Methotrexate—psoriasis	0.000178	0.00121	CcSEcCtD
Phenobarbital—Hallucination—Dexamethasone—psoriasis	0.000178	0.00121	CcSEcCtD
Phenobarbital—Hallucination—Betamethasone—psoriasis	0.000178	0.00121	CcSEcCtD
Phenobarbital—Ataxia—Methotrexate—psoriasis	0.000177	0.0012	CcSEcCtD
Phenobarbital—Pain—Mycophenolic acid—psoriasis	0.000177	0.0012	CcSEcCtD
Phenobarbital—Constipation—Mycophenolic acid—psoriasis	0.000177	0.0012	CcSEcCtD
Phenobarbital—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.000176	0.00119	CcSEcCtD
Phenobarbital—Arthralgia—Cyclosporine—psoriasis	0.000174	0.00119	CcSEcCtD
Phenobarbital—Myalgia—Cyclosporine—psoriasis	0.000174	0.00119	CcSEcCtD
Phenobarbital—Anxiety—Cyclosporine—psoriasis	0.000174	0.00118	CcSEcCtD
Phenobarbital—Erythema—Triamcinolone—psoriasis	0.000171	0.00117	CcSEcCtD
Phenobarbital—Angioedema—Prednisolone—psoriasis	0.00017	0.00116	CcSEcCtD
Phenobarbital—Feeling abnormal—Mycophenolic acid—psoriasis	0.00017	0.00116	CcSEcCtD
Phenobarbital—Arthralgia—Mycophenolate mofetil—psoriasis	0.00017	0.00116	CcSEcCtD
Phenobarbital—Myalgia—Mycophenolate mofetil—psoriasis	0.00017	0.00116	CcSEcCtD
Phenobarbital—Anxiety—Mycophenolate mofetil—psoriasis	0.00017	0.00115	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Methotrexate—psoriasis	0.000169	0.00115	CcSEcCtD
Phenobarbital—Confusional state—Cyclosporine—psoriasis	0.000169	0.00115	CcSEcCtD
Phenobarbital—Vertigo—Prednisolone—psoriasis	0.000168	0.00114	CcSEcCtD
Phenobarbital—Syncope—Prednisolone—psoriasis	0.000167	0.00114	CcSEcCtD
Phenobarbital—Angioedema—Hydrocortisone—psoriasis	0.000166	0.00113	CcSEcCtD
Phenobarbital—Confusional state—Mycophenolate mofetil—psoriasis	0.000164	0.00112	CcSEcCtD
Phenobarbital—Loss of consciousness—Prednisolone—psoriasis	0.000164	0.00111	CcSEcCtD
Phenobarbital—Vertigo—Hydrocortisone—psoriasis	0.000164	0.00111	CcSEcCtD
Phenobarbital—Body temperature increased—Mycophenolic acid—psoriasis	0.000163	0.00111	CcSEcCtD
Phenobarbital—Syncope—Hydrocortisone—psoriasis	0.000163	0.00111	CcSEcCtD
Phenobarbital—Dizziness—Hydroxyurea—psoriasis	0.000163	0.00111	CcSEcCtD
Phenobarbital—Asthma—Methotrexate—psoriasis	0.000163	0.0011	CcSEcCtD
Phenobarbital—Shock—Mycophenolate mofetil—psoriasis	0.00016	0.00109	CcSEcCtD
Phenobarbital—Loss of consciousness—Hydrocortisone—psoriasis	0.00016	0.00109	CcSEcCtD
Phenobarbital—Bradycardia—Prednisone—psoriasis	0.000158	0.00108	CcSEcCtD
Phenobarbital—Vomiting—Hydroxyurea—psoriasis	0.000157	0.00107	CcSEcCtD
Phenobarbital—Angioedema—Triamcinolone—psoriasis	0.000157	0.00106	CcSEcCtD
Phenobarbital—Rash—Hydroxyurea—psoriasis	0.000156	0.00106	CcSEcCtD
Phenobarbital—Erythema—Dexamethasone—psoriasis	0.000156	0.00106	CcSEcCtD
Phenobarbital—Erythema—Betamethasone—psoriasis	0.000156	0.00106	CcSEcCtD
Phenobarbital—Dermatitis—Hydroxyurea—psoriasis	0.000155	0.00106	CcSEcCtD
Phenobarbital—Myalgia—Hydrocortisone—psoriasis	0.000155	0.00105	CcSEcCtD
Phenobarbital—Hallucination—Prednisone—psoriasis	0.000155	0.00105	CcSEcCtD
Phenobarbital—Headache—Hydroxyurea—psoriasis	0.000155	0.00105	CcSEcCtD
Phenobarbital—Anxiety—Hydrocortisone—psoriasis	0.000154	0.00105	CcSEcCtD
Phenobarbital—Vertigo—Triamcinolone—psoriasis	0.000154	0.00105	CcSEcCtD
Phenobarbital—Syncope—Triamcinolone—psoriasis	0.000154	0.00105	CcSEcCtD
Phenobarbital—Hypotension—Mycophenolate mofetil—psoriasis	0.000152	0.00104	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000152	0.00104	CcSEcCtD
Phenobarbital—Loss of consciousness—Triamcinolone—psoriasis	0.000151	0.00102	CcSEcCtD
Phenobarbital—Shock—Prednisolone—psoriasis	0.00015	0.00102	CcSEcCtD
Phenobarbital—Somnolence—Cyclosporine—psoriasis	0.000149	0.00101	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000149	0.00101	CcSEcCtD
Phenobarbital—Nausea—Hydroxyurea—psoriasis	0.000147	0.000996	CcSEcCtD
Phenobarbital—Shock—Hydrocortisone—psoriasis	0.000146	0.000994	CcSEcCtD
Phenobarbital—Myalgia—Triamcinolone—psoriasis	0.000146	0.000992	CcSEcCtD
Phenobarbital—Somnolence—Mycophenolate mofetil—psoriasis	0.000145	0.000986	CcSEcCtD
Phenobarbital—Drowsiness—Methotrexate—psoriasis	0.000145	0.000985	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.000144	0.000976	CcSEcCtD
Phenobarbital—Pain—Cyclosporine—psoriasis	0.000143	0.000972	CcSEcCtD
Phenobarbital—Constipation—Cyclosporine—psoriasis	0.000143	0.000972	CcSEcCtD
Phenobarbital—Renal failure—Methotrexate—psoriasis	0.000142	0.000968	CcSEcCtD
Phenobarbital—Angioedema—Betamethasone—psoriasis	0.000142	0.000966	CcSEcCtD
Phenobarbital—Angioedema—Dexamethasone—psoriasis	0.000142	0.000966	CcSEcCtD
Phenobarbital—Vertigo—Dexamethasone—psoriasis	0.00014	0.00095	CcSEcCtD
Phenobarbital—Vertigo—Betamethasone—psoriasis	0.00014	0.00095	CcSEcCtD
Phenobarbital—Syncope—Betamethasone—psoriasis	0.00014	0.000948	CcSEcCtD
Phenobarbital—Syncope—Dexamethasone—psoriasis	0.00014	0.000948	CcSEcCtD
Phenobarbital—Constipation—Mycophenolate mofetil—psoriasis	0.00014	0.000948	CcSEcCtD
Phenobarbital—Pain—Mycophenolate mofetil—psoriasis	0.00014	0.000948	CcSEcCtD
Phenobarbital—Hypotension—Hydrocortisone—psoriasis	0.000139	0.000944	CcSEcCtD
Phenobarbital—Feeling abnormal—Cyclosporine—psoriasis	0.000138	0.000937	CcSEcCtD
Phenobarbital—Shock—Triamcinolone—psoriasis	0.000138	0.000936	CcSEcCtD
Phenobarbital—Loss of consciousness—Dexamethasone—psoriasis	0.000137	0.000929	CcSEcCtD
Phenobarbital—Loss of consciousness—Betamethasone—psoriasis	0.000137	0.000929	CcSEcCtD
Phenobarbital—Dizziness—Mycophenolic acid—psoriasis	0.000137	0.000929	CcSEcCtD
Phenobarbital—Erythema—Prednisone—psoriasis	0.000135	0.000921	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000135	0.00092	CcSEcCtD
Phenobarbital—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000134	0.000914	CcSEcCtD
Phenobarbital—Urticaria—Cyclosporine—psoriasis	0.000133	0.000903	CcSEcCtD
Phenobarbital—Myalgia—Dexamethasone—psoriasis	0.000132	0.0009	CcSEcCtD
Phenobarbital—Myalgia—Betamethasone—psoriasis	0.000132	0.0009	CcSEcCtD
Phenobarbital—Body temperature increased—Cyclosporine—psoriasis	0.000132	0.000898	CcSEcCtD
Phenobarbital—Anxiety—Dexamethasone—psoriasis	0.000132	0.000897	CcSEcCtD
Phenobarbital—Anxiety—Betamethasone—psoriasis	0.000132	0.000897	CcSEcCtD
Phenobarbital—Vomiting—Mycophenolic acid—psoriasis	0.000131	0.000893	CcSEcCtD
Phenobarbital—Rash—Mycophenolic acid—psoriasis	0.00013	0.000886	CcSEcCtD
Phenobarbital—Dermatitis—Mycophenolic acid—psoriasis	0.00013	0.000885	CcSEcCtD
Phenobarbital—Pain—Prednisolone—psoriasis	0.00013	0.000884	CcSEcCtD
Phenobarbital—Hepatitis—Methotrexate—psoriasis	0.00013	0.000884	CcSEcCtD
Phenobarbital—Urticaria—Mycophenolate mofetil—psoriasis	0.00013	0.000881	CcSEcCtD
Phenobarbital—Headache—Mycophenolic acid—psoriasis	0.000129	0.00088	CcSEcCtD
Phenobarbital—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000129	0.000876	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000127	0.000867	CcSEcCtD
Phenobarbital—Pain—Hydrocortisone—psoriasis	0.000127	0.000864	CcSEcCtD
Phenobarbital—Feeling abnormal—Prednisolone—psoriasis	0.000125	0.000852	CcSEcCtD
Phenobarbital—Shock—Betamethasone—psoriasis	0.000125	0.000849	CcSEcCtD
Phenobarbital—Shock—Dexamethasone—psoriasis	0.000125	0.000849	CcSEcCtD
Phenobarbital—Agitation—Prednisone—psoriasis	0.000125	0.000846	CcSEcCtD
Phenobarbital—Angioedema—Prednisone—psoriasis	0.000124	0.000841	CcSEcCtD
Phenobarbital—Hypersensitivity—Cyclosporine—psoriasis	0.000123	0.000837	CcSEcCtD
Phenobarbital—Erythema multiforme—Methotrexate—psoriasis	0.000123	0.000836	CcSEcCtD
Phenobarbital—Nausea—Mycophenolic acid—psoriasis	0.000123	0.000834	CcSEcCtD
Phenobarbital—Feeling abnormal—Hydrocortisone—psoriasis	0.000122	0.000832	CcSEcCtD
Phenobarbital—Vertigo—Prednisone—psoriasis	0.000122	0.000827	CcSEcCtD
Phenobarbital—Syncope—Prednisone—psoriasis	0.000122	0.000826	CcSEcCtD
Phenobarbital—Urticaria—Prednisolone—psoriasis	0.000121	0.000822	CcSEcCtD
Phenobarbital—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00012	0.000817	CcSEcCtD
Phenobarbital—Pain—Triamcinolone—psoriasis	0.00012	0.000813	CcSEcCtD
Phenobarbital—Loss of consciousness—Prednisone—psoriasis	0.000119	0.000809	CcSEcCtD
Phenobarbital—Hypotension—Betamethasone—psoriasis	0.000119	0.000806	CcSEcCtD
Phenobarbital—Hypotension—Dexamethasone—psoriasis	0.000119	0.000806	CcSEcCtD
Phenobarbital—Urticaria—Hydrocortisone—psoriasis	0.000118	0.000802	CcSEcCtD
Phenobarbital—Body temperature increased—Hydrocortisone—psoriasis	0.000117	0.000798	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000116	0.000786	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000116	0.000786	CcSEcCtD
Phenobarbital—Arthralgia—Prednisone—psoriasis	0.000115	0.000784	CcSEcCtD
Phenobarbital—Myalgia—Prednisone—psoriasis	0.000115	0.000784	CcSEcCtD
Phenobarbital—Feeling abnormal—Triamcinolone—psoriasis	0.000115	0.000784	CcSEcCtD
Phenobarbital—Anxiety—Prednisone—psoriasis	0.000115	0.000781	CcSEcCtD
Phenobarbital—Erythema—Methotrexate—psoriasis	0.000113	0.00077	CcSEcCtD
Phenobarbital—Hypersensitivity—Prednisolone—psoriasis	0.000112	0.000762	CcSEcCtD
Phenobarbital—Urticaria—Triamcinolone—psoriasis	0.000111	0.000756	CcSEcCtD
Phenobarbital—Body temperature increased—Triamcinolone—psoriasis	0.000111	0.000752	CcSEcCtD
Phenobarbital—Dizziness—Cyclosporine—psoriasis	0.000111	0.000752	CcSEcCtD
Phenobarbital—Hypersensitivity—Hydrocortisone—psoriasis	0.000109	0.000744	CcSEcCtD
Phenobarbital—Shock—Prednisone—psoriasis	0.000109	0.000739	CcSEcCtD
Phenobarbital—Pain—Betamethasone—psoriasis	0.000109	0.000738	CcSEcCtD
Phenobarbital—Pain—Dexamethasone—psoriasis	0.000109	0.000738	CcSEcCtD
Phenobarbital—Dizziness—Mycophenolate mofetil—psoriasis	0.000108	0.000733	CcSEcCtD
Phenobarbital—Vomiting—Cyclosporine—psoriasis	0.000106	0.000723	CcSEcCtD
Phenobarbital—Rash—Cyclosporine—psoriasis	0.000105	0.000717	CcSEcCtD
Phenobarbital—Dermatitis—Cyclosporine—psoriasis	0.000105	0.000716	CcSEcCtD
Phenobarbital—Headache—Cyclosporine—psoriasis	0.000105	0.000712	CcSEcCtD
Phenobarbital—Feeling abnormal—Dexamethasone—psoriasis	0.000105	0.000711	CcSEcCtD
Phenobarbital—Feeling abnormal—Betamethasone—psoriasis	0.000105	0.000711	CcSEcCtD
Phenobarbital—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000104	0.00127	CbGpPWpGaD
Phenobarbital—Vomiting—Mycophenolate mofetil—psoriasis	0.000104	0.000705	CcSEcCtD
Phenobarbital—ABCB1—Allograft Rejection—IL13—psoriasis	0.000103	0.00127	CbGpPWpGaD
Phenobarbital—Hypersensitivity—Triamcinolone—psoriasis	0.000103	0.000701	CcSEcCtD
Phenobarbital—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000103	0.00126	CbGpPWpGaD
Phenobarbital—Rash—Mycophenolate mofetil—psoriasis	0.000103	0.000699	CcSEcCtD
Phenobarbital—Dermatitis—Mycophenolate mofetil—psoriasis	0.000103	0.000698	CcSEcCtD
Phenobarbital—Headache—Mycophenolate mofetil—psoriasis	0.000102	0.000695	CcSEcCtD
Phenobarbital—GRIA2—BDNF signaling pathway—NFKBIA—psoriasis	0.000102	0.00125	CbGpPWpGaD
Phenobarbital—Vertigo—Methotrexate—psoriasis	0.000102	0.000691	CcSEcCtD
Phenobarbital—Urticaria—Betamethasone—psoriasis	0.000101	0.000686	CcSEcCtD
Phenobarbital—Urticaria—Dexamethasone—psoriasis	0.000101	0.000686	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Prednisone—psoriasis	0.000101	0.000685	CcSEcCtD
Phenobarbital—Dizziness—Prednisolone—psoriasis	0.000101	0.000684	CcSEcCtD
Phenobarbital—Body temperature increased—Betamethasone—psoriasis	0.0001	0.000682	CcSEcCtD
Phenobarbital—Body temperature increased—Dexamethasone—psoriasis	0.0001	0.000682	CcSEcCtD
Phenobarbital—Nausea—Cyclosporine—psoriasis	9.93e-05	0.000675	CcSEcCtD
Phenobarbital—CYP1B1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	9.91e-05	0.00121	CbGpPWpGaD
Phenobarbital—Dizziness—Hydrocortisone—psoriasis	9.83e-05	0.000668	CcSEcCtD
Phenobarbital—CYP1A2—Biological oxidations—CYP2S1—psoriasis	9.77e-05	0.0012	CbGpPWpGaD
Phenobarbital—Nausea—Mycophenolate mofetil—psoriasis	9.69e-05	0.000659	CcSEcCtD
Phenobarbital—Arthralgia—Methotrexate—psoriasis	9.64e-05	0.000655	CcSEcCtD
Phenobarbital—Myalgia—Methotrexate—psoriasis	9.64e-05	0.000655	CcSEcCtD
Phenobarbital—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	9.63e-05	0.00118	CbGpPWpGaD
Phenobarbital—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	9.62e-05	0.00118	CbGpPWpGaD
Phenobarbital—Rash—Prednisolone—psoriasis	9.59e-05	0.000652	CcSEcCtD
Phenobarbital—Dermatitis—Prednisolone—psoriasis	9.59e-05	0.000652	CcSEcCtD
Phenobarbital—Headache—Prednisolone—psoriasis	9.53e-05	0.000648	CcSEcCtD
Phenobarbital—ABCB1—Allograft Rejection—IL17A—psoriasis	9.51e-05	0.00116	CbGpPWpGaD
Phenobarbital—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	9.47e-05	0.00116	CbGpPWpGaD
Phenobarbital—Constipation—Prednisone—psoriasis	9.46e-05	0.000643	CcSEcCtD
Phenobarbital—Vomiting—Hydrocortisone—psoriasis	9.45e-05	0.000642	CcSEcCtD
Phenobarbital—Rash—Hydrocortisone—psoriasis	9.37e-05	0.000637	CcSEcCtD
Phenobarbital—Dermatitis—Hydrocortisone—psoriasis	9.36e-05	0.000636	CcSEcCtD
Phenobarbital—Confusional state—Methotrexate—psoriasis	9.32e-05	0.000633	CcSEcCtD
Phenobarbital—Headache—Hydrocortisone—psoriasis	9.31e-05	0.000633	CcSEcCtD
Phenobarbital—Dizziness—Triamcinolone—psoriasis	9.25e-05	0.000629	CcSEcCtD
Phenobarbital—Feeling abnormal—Prednisone—psoriasis	9.11e-05	0.000619	CcSEcCtD
Phenobarbital—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.1e-05	0.00111	CbGpPWpGaD
Phenobarbital—Nausea—Prednisolone—psoriasis	9.04e-05	0.000614	CcSEcCtD
Phenobarbital—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	9e-05	0.0011	CbGpPWpGaD
Phenobarbital—Vomiting—Triamcinolone—psoriasis	8.9e-05	0.000605	CcSEcCtD
Phenobarbital—ABCB1—Allograft Rejection—IL12B—psoriasis	8.84e-05	0.00108	CbGpPWpGaD
Phenobarbital—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	8.83e-05	0.00108	CbGpPWpGaD
Phenobarbital—Nausea—Hydrocortisone—psoriasis	8.83e-05	0.0006	CcSEcCtD
Phenobarbital—Rash—Triamcinolone—psoriasis	8.82e-05	0.0006	CcSEcCtD
Phenobarbital—Dermatitis—Triamcinolone—psoriasis	8.82e-05	0.000599	CcSEcCtD
Phenobarbital—Urticaria—Prednisone—psoriasis	8.78e-05	0.000597	CcSEcCtD
Phenobarbital—Headache—Triamcinolone—psoriasis	8.77e-05	0.000596	CcSEcCtD
Phenobarbital—Body temperature increased—Prednisone—psoriasis	8.74e-05	0.000594	CcSEcCtD
Phenobarbital—Hypotension—Methotrexate—psoriasis	8.64e-05	0.000587	CcSEcCtD
Phenobarbital—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.63e-05	0.00106	CbGpPWpGaD
Phenobarbital—CYP1A1—Oxidative Stress—NFKB1—psoriasis	8.6e-05	0.00105	CbGpPWpGaD
Phenobarbital—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.5e-05	0.00104	CbGpPWpGaD
Phenobarbital—CYP1A2—Tryptophan metabolism—CAT—psoriasis	8.43e-05	0.00103	CbGpPWpGaD
Phenobarbital—Musculoskeletal discomfort—Methotrexate—psoriasis	8.42e-05	0.000572	CcSEcCtD
Phenobarbital—Dizziness—Dexamethasone—psoriasis	8.4e-05	0.000571	CcSEcCtD
Phenobarbital—Dizziness—Betamethasone—psoriasis	8.4e-05	0.000571	CcSEcCtD
Phenobarbital—Nausea—Triamcinolone—psoriasis	8.31e-05	0.000565	CcSEcCtD
Phenobarbital—Somnolence—Methotrexate—psoriasis	8.22e-05	0.000558	CcSEcCtD
Phenobarbital—Hypersensitivity—Prednisone—psoriasis	8.15e-05	0.000554	CcSEcCtD
Phenobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—psoriasis	8.1e-05	0.000992	CbGpPWpGaD
Phenobarbital—Vomiting—Dexamethasone—psoriasis	8.07e-05	0.000549	CcSEcCtD
Phenobarbital—Vomiting—Betamethasone—psoriasis	8.07e-05	0.000549	CcSEcCtD
Phenobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.04e-05	0.000984	CbGpPWpGaD
Phenobarbital—Rash—Dexamethasone—psoriasis	8.01e-05	0.000544	CcSEcCtD
Phenobarbital—Rash—Betamethasone—psoriasis	8.01e-05	0.000544	CcSEcCtD
Phenobarbital—Dermatitis—Dexamethasone—psoriasis	8e-05	0.000544	CcSEcCtD
Phenobarbital—Dermatitis—Betamethasone—psoriasis	8e-05	0.000544	CcSEcCtD
Phenobarbital—Headache—Dexamethasone—psoriasis	7.95e-05	0.000541	CcSEcCtD
Phenobarbital—Headache—Betamethasone—psoriasis	7.95e-05	0.000541	CcSEcCtD
Phenobarbital—Pain—Methotrexate—psoriasis	7.9e-05	0.000537	CcSEcCtD
Phenobarbital—CYP4A11—Metabolism—NDUFA5—psoriasis	7.76e-05	0.00095	CbGpPWpGaD
Phenobarbital—CYP1B1—Aryl Hydrocarbon Receptor—TNF—psoriasis	7.71e-05	0.000944	CbGpPWpGaD
Phenobarbital—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	7.71e-05	0.000944	CbGpPWpGaD
Phenobarbital—Feeling abnormal—Methotrexate—psoriasis	7.62e-05	0.000518	CcSEcCtD
Phenobarbital—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	7.57e-05	0.000926	CbGpPWpGaD
Phenobarbital—Nausea—Dexamethasone—psoriasis	7.54e-05	0.000513	CcSEcCtD
Phenobarbital—Nausea—Betamethasone—psoriasis	7.54e-05	0.000513	CcSEcCtD
Phenobarbital—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.54e-05	0.000923	CbGpPWpGaD
Phenobarbital—CHRNA7—SIDS Susceptibility Pathways—JUN—psoriasis	7.53e-05	0.000922	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—psoriasis	7.48e-05	0.000916	CbGpPWpGaD
Phenobarbital—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.43e-05	0.00091	CbGpPWpGaD
Phenobarbital—Urticaria—Methotrexate—psoriasis	7.34e-05	0.000499	CcSEcCtD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.34e-05	0.000898	CbGpPWpGaD
Phenobarbital—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	7.33e-05	0.000897	CbGpPWpGaD
Phenobarbital—Dizziness—Prednisone—psoriasis	7.31e-05	0.000497	CcSEcCtD
Phenobarbital—Body temperature increased—Methotrexate—psoriasis	7.31e-05	0.000497	CcSEcCtD
Phenobarbital—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.26e-05	0.000889	CbGpPWpGaD
Phenobarbital—CHRNA7—SIDS Susceptibility Pathways—NFKB1—psoriasis	7.25e-05	0.000888	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.24e-05	0.000886	CbGpPWpGaD
Phenobarbital—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7.23e-05	0.000885	CbGpPWpGaD
Phenobarbital—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	7.21e-05	0.000883	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.14e-05	0.000875	CbGpPWpGaD
Phenobarbital—Vomiting—Prednisone—psoriasis	7.03e-05	0.000478	CcSEcCtD
Phenobarbital—Rash—Prednisone—psoriasis	6.97e-05	0.000474	CcSEcCtD
Phenobarbital—Dermatitis—Prednisone—psoriasis	6.97e-05	0.000473	CcSEcCtD
Phenobarbital—Headache—Prednisone—psoriasis	6.93e-05	0.000471	CcSEcCtD
Phenobarbital—ABCB11—Metabolism—NDUFA5—psoriasis	6.88e-05	0.000843	CbGpPWpGaD
Phenobarbital—Hypersensitivity—Methotrexate—psoriasis	6.81e-05	0.000463	CcSEcCtD
Phenobarbital—CYP2C18—Metabolism—NDUFA5—psoriasis	6.79e-05	0.000831	CbGpPWpGaD
Phenobarbital—GRIA2—BDNF signaling pathway—JUN—psoriasis	6.75e-05	0.000827	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.65e-05	0.000814	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—psoriasis	6.61e-05	0.000809	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—NDUFA5—psoriasis	6.6e-05	0.000808	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—CYP2S1—psoriasis	6.6e-05	0.000808	CbGpPWpGaD
Phenobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—psoriasis	6.58e-05	0.000806	CbGpPWpGaD
Phenobarbital—Nausea—Prednisone—psoriasis	6.57e-05	0.000446	CcSEcCtD
Phenobarbital—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.5e-05	0.000796	CbGpPWpGaD
Phenobarbital—GRIA2—BDNF signaling pathway—NFKB1—psoriasis	6.5e-05	0.000796	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—IL10—psoriasis	6.47e-05	0.000792	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.42e-05	0.000786	CbGpPWpGaD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.34e-05	0.000777	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—IL4—psoriasis	6.29e-05	0.00077	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—CARM1—psoriasis	6.2e-05	0.000759	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.15e-05	0.000753	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.15e-05	0.000753	CbGpPWpGaD
Phenobarbital—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.14e-05	0.000752	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—JUN—psoriasis	6.14e-05	0.000752	CbGpPWpGaD
Phenobarbital—ABCC3—Transmembrane transport of small molecules—CP—psoriasis	6.13e-05	0.000751	CbGpPWpGaD
Phenobarbital—Dizziness—Methotrexate—psoriasis	6.11e-05	0.000415	CcSEcCtD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.11e-05	0.000747	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.91e-05	0.000724	CbGpPWpGaD
Phenobarbital—Vomiting—Methotrexate—psoriasis	5.88e-05	0.000399	CcSEcCtD
Phenobarbital—ABCB11—Metabolism—CYP2S1—psoriasis	5.85e-05	0.000717	CbGpPWpGaD
Phenobarbital—ABCC3—Transmembrane transport of small molecules—CARM1—psoriasis	5.85e-05	0.000716	CbGpPWpGaD
Phenobarbital—GRIA2—BDNF signaling pathway—STAT3—psoriasis	5.84e-05	0.000715	CbGpPWpGaD
Phenobarbital—Rash—Methotrexate—psoriasis	5.83e-05	0.000396	CcSEcCtD
Phenobarbital—Dermatitis—Methotrexate—psoriasis	5.82e-05	0.000396	CcSEcCtD
Phenobarbital—CYP4B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.79e-05	0.000709	CbGpPWpGaD
Phenobarbital—Headache—Methotrexate—psoriasis	5.79e-05	0.000393	CcSEcCtD
Phenobarbital—CYP2C18—Metabolism—CYP2S1—psoriasis	5.77e-05	0.000706	CbGpPWpGaD
Phenobarbital—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.72e-05	0.000701	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.7e-05	0.000698	CbGpPWpGaD
Phenobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—psoriasis	5.64e-05	0.000691	CbGpPWpGaD
Phenobarbital—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	5.63e-05	0.000689	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—CYP2S1—psoriasis	5.61e-05	0.000687	CbGpPWpGaD
Phenobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.6e-05	0.000686	CbGpPWpGaD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.54e-05	0.000678	CbGpPWpGaD
Phenobarbital—Nausea—Methotrexate—psoriasis	5.49e-05	0.000373	CcSEcCtD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—psoriasis	5.37e-05	0.000657	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.21e-05	0.000637	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—NDUFA5—psoriasis	5.17e-05	0.000633	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—NDUFA5—psoriasis	5e-05	0.000612	CbGpPWpGaD
Phenobarbital—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	4.86e-05	0.000595	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.82e-05	0.00059	CbGpPWpGaD
Phenobarbital—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	4.81e-05	0.000588	CbGpPWpGaD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.75e-05	0.000581	CbGpPWpGaD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.75e-05	0.000581	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.68e-05	0.000573	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.66e-05	0.000571	CbGpPWpGaD
Phenobarbital—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	4.64e-05	0.000568	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—psoriasis	4.6e-05	0.000563	CbGpPWpGaD
Phenobarbital—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	4.59e-05	0.000561	CbGpPWpGaD
Phenobarbital—GABRA1—Transmembrane transport of small molecules—CP—psoriasis	4.56e-05	0.000558	CbGpPWpGaD
Phenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—psoriasis	4.55e-05	0.000557	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—NDUFA5—psoriasis	4.51e-05	0.000552	CbGpPWpGaD
Phenobarbital—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	4.45e-05	0.000545	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—CYP2S1—psoriasis	4.4e-05	0.000538	CbGpPWpGaD
Phenobarbital—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	4.36e-05	0.000533	CbGpPWpGaD
Phenobarbital—GABRA1—Transmembrane transport of small molecules—CARM1—psoriasis	4.35e-05	0.000532	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—CYP2S1—psoriasis	4.25e-05	0.000521	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—NDUFA5—psoriasis	4.13e-05	0.000506	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—psoriasis	4.09e-05	0.000501	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.04e-05	0.000495	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.89e-05	0.000477	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CYP2S1—psoriasis	3.84e-05	0.00047	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—CAT—psoriasis	3.81e-05	0.000467	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—IFNG—psoriasis	3.8e-05	0.000466	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—JUN—psoriasis	3.8e-05	0.000466	CbGpPWpGaD
Phenobarbital—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.8e-05	0.000465	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—psoriasis	3.71e-05	0.000454	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—NFKB1—psoriasis	3.66e-05	0.000448	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.54e-05	0.000433	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.53e-05	0.000433	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CYP2S1—psoriasis	3.52e-05	0.00043	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.46e-05	0.000423	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—NDUFA5—psoriasis	3.34e-05	0.000408	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—psoriasis	3.32e-05	0.000407	CbGpPWpGaD
Phenobarbital—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.32e-05	0.000406	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—NDUFA5—psoriasis	3.27e-05	0.0004	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—NDUFA5—psoriasis	3.26e-05	0.000399	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—CARM1—psoriasis	3.22e-05	0.000395	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—NDUFA5—psoriasis	3.08e-05	0.000377	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.07e-05	0.000376	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.03e-05	0.000371	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.03e-05	0.000371	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.01e-05	0.000369	CbGpPWpGaD
Phenobarbital—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	3e-05	0.000368	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—APOE—psoriasis	2.96e-05	0.000363	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.94e-05	0.00036	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.91e-05	0.000356	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.87e-05	0.000352	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.87e-05	0.000352	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—CARM1—psoriasis	2.86e-05	0.00035	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—psoriasis	2.85e-05	0.000349	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CYP2S1—psoriasis	2.84e-05	0.000347	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—NDUFA5—psoriasis	2.82e-05	0.000346	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—CARM1—psoriasis	2.82e-05	0.000345	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CYP2S1—psoriasis	2.78e-05	0.00034	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CYP2S1—psoriasis	2.77e-05	0.000339	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—CARM1—psoriasis	2.74e-05	0.000336	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.67e-05	0.000327	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.63e-05	0.000322	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CYP2S1—psoriasis	2.62e-05	0.000321	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—PPARG—psoriasis	2.58e-05	0.000316	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.56e-05	0.000314	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—NDUFA5—psoriasis	2.52e-05	0.000309	CbGpPWpGaD
Phenobarbital—ABCB1—Allograft Rejection—TNF—psoriasis	2.46e-05	0.000301	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—NDUFA5—psoriasis	2.46e-05	0.000301	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.45e-05	0.0003	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CYP2S1—psoriasis	2.4e-05	0.000294	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.35e-05	0.000288	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.3e-05	0.000282	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—NDUFA5—psoriasis	2.3e-05	0.000281	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—psoriasis	2.3e-05	0.000281	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.29e-05	0.00028	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.23e-05	0.000273	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.18e-05	0.000267	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—CARM1—psoriasis	2.15e-05	0.000263	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYP2S1—psoriasis	2.14e-05	0.000262	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.14e-05	0.000262	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYP2S1—psoriasis	2.09e-05	0.000256	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—CARM1—psoriasis	2.08e-05	0.000254	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.01e-05	0.000246	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—CAT—psoriasis	1.98e-05	0.000243	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NDUFA5—psoriasis	1.96e-05	0.00024	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYP2S1—psoriasis	1.95e-05	0.000239	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.94e-05	0.000238	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CARM1—psoriasis	1.87e-05	0.000229	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.83e-05	0.000224	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—CAT—psoriasis	1.76e-05	0.000215	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—CAT—psoriasis	1.73e-05	0.000212	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CARM1—psoriasis	1.72e-05	0.00021	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—CAT—psoriasis	1.69e-05	0.000206	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP2S1—psoriasis	1.67e-05	0.000204	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.62e-05	0.000199	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.56e-05	0.000191	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—APOE—psoriasis	1.54e-05	0.000189	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NDUFA5—psoriasis	1.52e-05	0.000186	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.42e-05	0.000173	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CARM1—psoriasis	1.39e-05	0.00017	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.37e-05	0.000168	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—APOE—psoriasis	1.37e-05	0.000167	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CARM1—psoriasis	1.36e-05	0.000166	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CARM1—psoriasis	1.35e-05	0.000166	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—APOE—psoriasis	1.35e-05	0.000165	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PPARG—psoriasis	1.34e-05	0.000164	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—CAT—psoriasis	1.32e-05	0.000162	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—HLA-A—psoriasis	1.31e-05	0.000161	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—APOE—psoriasis	1.31e-05	0.00016	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP2S1—psoriasis	1.29e-05	0.000158	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CARM1—psoriasis	1.28e-05	0.000157	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—CAT—psoriasis	1.28e-05	0.000156	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.26e-05	0.000154	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—APOE—psoriasis	1.23e-05	0.00015	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.21e-05	0.000149	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.2e-05	0.000146	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PPARG—psoriasis	1.19e-05	0.000146	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PPARG—psoriasis	1.17e-05	0.000144	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CARM1—psoriasis	1.17e-05	0.000144	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CAT—psoriasis	1.15e-05	0.000141	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—NOS2—psoriasis	1.14e-05	0.00014	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PPARG—psoriasis	1.14e-05	0.00014	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.12e-05	0.000138	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.1e-05	0.000134	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.07e-05	0.000131	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CAT—psoriasis	1.06e-05	0.000129	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CARM1—psoriasis	1.05e-05	0.000128	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—APOE—psoriasis	1.03e-05	0.000126	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.02e-05	0.000125	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CARM1—psoriasis	1.02e-05	0.000125	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—APOE—psoriasis	9.93e-06	0.000122	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.78e-06	0.00012	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CARM1—psoriasis	9.54e-06	0.000117	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—TYK2—psoriasis	9.35e-06	0.000115	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—APOE—psoriasis	8.95e-06	0.00011	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PPARG—psoriasis	8.94e-06	0.000109	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.92e-06	0.000109	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.75e-06	0.000107	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PPARG—psoriasis	8.65e-06	0.000106	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CAT—psoriasis	8.52e-06	0.000104	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CD4—psoriasis	8.46e-06	0.000104	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CAT—psoriasis	8.35e-06	0.000102	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CAT—psoriasis	8.33e-06	0.000102	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—APOE—psoriasis	8.21e-06	0.0001	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CARM1—psoriasis	8.16e-06	9.98e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CAT—psoriasis	7.87e-06	9.63e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PPARG—psoriasis	7.8e-06	9.55e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.62e-06	9.33e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CAT—psoriasis	7.21e-06	8.83e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PPARG—psoriasis	7.15e-06	8.75e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—APOE—psoriasis	6.62e-06	8.1e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—STAT3—psoriasis	6.55e-06	8.02e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—APOE—psoriasis	6.48e-06	7.94e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—APOE—psoriasis	6.47e-06	7.92e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CAT—psoriasis	6.44e-06	7.88e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CARM1—psoriasis	6.29e-06	7.71e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CAT—psoriasis	6.28e-06	7.69e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—APOE—psoriasis	6.11e-06	7.48e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CAT—psoriasis	5.87e-06	7.19e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PPARG—psoriasis	5.77e-06	7.06e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PPARG—psoriasis	5.65e-06	6.91e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PPARG—psoriasis	5.64e-06	6.9e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—APOE—psoriasis	5.6e-06	6.86e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PPARG—psoriasis	5.32e-06	6.52e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CAT—psoriasis	5.02e-06	6.14e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—APOE—psoriasis	5e-06	6.12e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—APOE—psoriasis	4.88e-06	5.98e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PPARG—psoriasis	4.88e-06	5.98e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—IL6—psoriasis	4.57e-06	5.6e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—APOE—psoriasis	4.56e-06	5.58e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PPARG—psoriasis	4.36e-06	5.33e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PPARG—psoriasis	4.25e-06	5.21e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PPARG—psoriasis	3.97e-06	4.86e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—APOE—psoriasis	3.9e-06	4.77e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CAT—psoriasis	3.87e-06	4.74e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PPARG—psoriasis	3.4e-06	4.16e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—APOE—psoriasis	3.01e-06	3.68e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PPARG—psoriasis	2.62e-06	3.21e-05	CbGpPWpGaD
